Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 immunobiology in glomerulonephritis and renal cell carcinoma
Colleen S. Curran, Jeffrey B. Kopp
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 290
Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease
Jeffrey W. Pippin, Natalya Kaverina, Yuliang Wang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 54
The interaction of innate immune and adaptive immune system
Ruyuan Wang, Caini Lan, Kamel Benlagha, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 15
TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts
Kapetanaki Stefania, Kumawat Kumar Ashok, Paramel Varghese Geena, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
New progress in the treatment of diffuse midline glioma with H3K27M alteration
Zhi Yang, Liang Sun, Hai‐Bin Chen, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24877-e24877
Open Access | Times Cited: 5
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
Colleen S. Curran, Jeffrey B. Kopp
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
RAGE pathway activation and function in chronic kidney disease and COVID-19
Colleen S. Curran, Jeffrey B. Kopp
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
Alexandre O. Gérard, Diane Merino, Jonathan Benzaquen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk
Alfredo Erazo‐Oliveras, Mónica Muñoz‐Vega, Michael L. Salinas, et al.
FEBS Journal (2022) Vol. 291, Iss. 7, pp. 1299-1352
Open Access | Times Cited: 15
Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis
Liuting Zhou, Zhenyan Ye, Erqing Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1531-1547
Open Access | Times Cited: 12
PD-1 immunology in the kidneys: a growing relationship
Ruyue Chen, Qiang Lin, Hanyun Tang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
Lu Wen, Fan Tong, Ruiguang Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
Shehjar R. Trisal, Gary Low, Faraz Pathan, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 7, pp. 843-849
Closed Access | Times Cited: 5
Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Tao Li, Huiyun Zhang, Guangyu An, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Deep Learning–Based Classification of Epithelial–Mesenchymal Transition for Predicting Response to Therapy in Clear Cell Renal Cell Carcinoma
Qiwei Chen, Yue Kuai, Shujing Wang, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 5
Diminished PD-L1 regulation along with dysregulated T lymphocyte subsets and chemokine in ANCA-associated vasculitis
Jagdeep Singh, Ranjana W. Minz, Biman Saikia, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1801-1813
Closed Access | Times Cited: 3
Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity
Yanyan Zheng, Zheng Lu, Fei Zhu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113004-113004
Closed Access
Identification of key necroptosis-related genes and immune landscape in patients with immunoglobulin A nephropathy
Ruikun Hu, Ziyu Liu, Hou H, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
Lin Hou, Xinyue Liu
Genetics Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 1
Cancer and Immunology – The Homeostasis Dance
Bene Ekine-Afolabi
Springer eBooks (2023), pp. 1-38
Closed Access | Times Cited: 1
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
Jordi Guiteras, Elena Crespo, Pere Fontova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8411-8411
Open Access | Times Cited: 2
Cancer and Immunology-the Homeostasis Dance
Bene Ekine-Afolabi
Journal of Modern Medical Oncology (2022) Vol. 2, pp. 5-5
Open Access | Times Cited: 1
Upregulated PD-1 Signaling is an Important Antagonist to Glomerular Health in Aged Kidneys
Jeffrey W. Pippin, Natalya Kaverina, Yuliang Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Identification and validation of a prognostic risk score model for lung adenocarcinoma constructed based on immunogenic cell death
guijuan xie, Yiming Xu, Liang Bao, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top